Isobel Markham
The sale comes as the Bahraini firm, led by Mohammed Mahfoodh Al Ardhi, embarks on its ambitious growth plan.
The London-based firm is currently in market with its eighth flagship fund, targeting €1.6 billion.
The firm’s head of Turkey says macro issues are not affecting investment pace, and expects to close 4-5 investments in the next two years.
John Brooks, former chief executive of Joslin Diabetes Center, will help to identify new investment opportunities.
Christian Kvorning, an investment director at the €31.5bn Danish pension fund’s alternatives arm, on worsening fund terms, the need for a ‘healthy crisis’ and elusive US managers.
Despite an onslaught of challenges, the emerging markets specialist has raised $526 million for its debut Turkey-dedicated vehicle.
Originally targeting $400m, Fund IX is the firm’s largest fund of funds to date.
Noble will retain her role at the DFI as well as working with UK bank-backed BGF, a growth capital investor.
In its annual review, the $773bn Abu Dhabi sovereign wealth fund reported a fall in 20- and 30-year annualised returns against a 'backdrop of slowing global growth'.
The mezzanine provider has seen a 2% increase in third-party fee-earning AUM.